The nuclear medicine and theranostics procedures in Mexico City provide specialized diagnostic studies and targeted treatments that analyze organ function at the cellular level. Utilizing advanced molecular imaging and targeted radionuclide therapies, these procedures enable early disease detection, precise cancer staging, and effective treatment for thyroid disorders and neuroendocrine tumors.
International patients undergoing nuclear medicine procedures in Mexico City access cutting-edge technology, including PSMA PET scans, Radioactive Iodine (I-131) therapy, and Lutetium-177 (Lu-177) theranostics. Every procedure is performed by a board-certified nuclear medicine physician, delivering reliable evidence-based outcomes, shorter wait times, and comprehensive post-treatment follow-up.